X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ACTA DIABETOLOGICA

期刊標題檢索 ACTA DIABETOL 最新評論: 10-18 submitted, 10-21 with editor, 10-27 no change; 10-22 submitt... (2024-10-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ACTA DIABETOLOGICA]您好,您是該頁面的第 30259 位訪客。

期刊簡介
期刊名稱ACTA DIABETOLOGICA ACTA DIABETOLOGICA
LetPub Score
6.4
50 ratings
Rate

Reputation
7.5

Influence
5.1

Speed
8.8

期刊簡稱ACTA DIABETOL
ISSN0940-5429
E-ISSN1432-5233
h-index56
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.300.9800.943
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Internal Medicine
Q131 / 167
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q161 / 244
Category: Medicine
Subcategory: Endocrinology
Q240 / 128

自引率 (2023-2024)3.20%自引率趨勢
掲載範囲
Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
官方網站https://www.springer.com/592
在線稿件提交https://www.editorialmanager.com/acdi/
開放訪問No
出版商Springer Milan
主題領域医学
出版國/地區ITALY
發行頻率四半期刊行
創刊年1964
每年文章數169每年文章數趨勢
黃金OA百分比39.24%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ285/186
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0940-5429%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【ACTA DIABETOLOGICA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE191601
    Cell Metabolism129844
    DIABETES101915
    JOURNAL OF PINEAL RESEARCH97640
    BIOLOGICAL TRACE ELEMENT RESEARCH92856
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81289
    ANTIOXIDANTS & REDOX SIGNALING79909
    DIABETES CARE73453
    BONE70437
    Obesity68336
  •  

    ACTA DIABETOLOGICA ACTA DIABETOLOGICA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [ACTA DIABETOLOGICA] 的評論撰寫評論
作者: keyanlabourer


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 15:18:15 評論於
10-18 submitted, 10-21 with editor, 10-27 no change;
10-22 submitted to journal, 10-24 with editor, 10-28 under review
No further updates, it's moving slowly.
(0) 讚! | keyanlabourer

作者: Gary Austin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 21:56:01 評論於
Excuse me, have you found it?
(0) 讚! | Gary Austin

作者: Gary Austin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 18:48:02 評論於
Could you please tell me where to download the Conflict of Interest Form?
(0) 讚! | Gary Austin

作者: SCI


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 23:01:59 評論於
Excuse me, how long until the change? WE all along.
(0) 讚! | SCI

作者: SCI


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 23:00:30 評論於
How long have we been going on?
(0) 讚! | SCI

作者: 凌波东海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-25 16:59:34 評論於
Do communication and the first author need to have ORCID?
(0) 讚! | 凌波东海

作者: 中原玉惠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-21 23:49:06 評論於
Hello, may I ask if you have found it? Where can I download it?
(0) 讚! | 中原玉惠

作者: 京城丝柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 16:26:25 評論於
Takako, how is the article going?
(0) 讚! | 京城丝柳

作者: 京城丝柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 10:31:06 評論於
Please translate the following paragraph into English and Japanese, and use ": " and "
(0) 讚! | 京城丝柳

作者: Isaac Emily


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 08:15:53 評論於
How are you, my dear?
(0) 讚! | Isaac Emily

作者: 震雷春柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 23:24:30 評論於
How long will the editor last? I'm getting a little anxious
(0) 讚! | 震雷春柳

作者: 碧桃笑柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-15 19:15:36 評論於
How long have you been with the editor?
(0) 讚! | 碧桃笑柳

作者: 碧水驰月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-08 15:29:21 評論於
How are you doing now?
(0) 讚! | 碧水驰月

作者: 是你的兰月呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-11 08:24:03 評論於
Hello, may I ask what is the current status?
(0) 讚! | 是你的兰月呀

作者: 灵雨姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 16:16:59 評論於
On the fifth day, I have a meeting with the editor. I wonder what will happen next
(0) 讚! | 灵雨姑娘

作者: 灵雨姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-10 14:09:55 評論於
Submission success rate: 5.0
Experience sharing: Submitted to Journal three days ago and still no response, getting worried
(0) 讚! | 灵雨姑娘

作者: Burgess Webster


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-16 12:04:31 評論於
6.1 with editor   What is the situation with the editor until now? Most of the journals I submitted to before would send rejection messages in less than a week
(0) 讚! | Burgess Webster

作者: 卡什黑兹利特


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-12 11:04:43 評論於
How long did the with editor last, thank you
(0) 讚! | 卡什黑兹利特

作者: 安晏小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-07 16:08:17 評論於
Submitted for a month and a half, rejected. Sent to two reviewers, the first reviewer was very friendly and basically accepted it directly. The second reviewer's comments were very unfriendly, and it felt like they didn't take my article seriously at all. They misunderstood my conclusions and their suggestions were all based on the limitations I wrote. In the end, it was rejected, and I feel very upset and want to argue
(0) 讚! | 安晏小郎君

作者: 卡什黑兹利特


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-05 16:53:53 評論於
How long has the with editor session been going on?
(0) 讚! | 卡什黑兹利特

作者: 降龙金涛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-13 22:15:52 評論於
How are you doing lately?
(0) 讚! | 降龙金涛

作者: 冰云大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-17 08:35:56 評論於
How long does it take for you to reply?
(0) 讚! | 冰云大叔

作者: 冰云大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-14 16:27:18 評論於
It's been almost three months since I submitted my manuscript, and it has been in "with editor" status the whole time. I'm wondering if this is the normal status for this journal, and how long does it usually take for editors to respond?
(0) 讚! | 冰云大叔

作者: 卧龙秋寒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-04 16:29:30 評論於
Where can I download the conflict of interest form? Thank you!
(0) 讚! | 卧龙秋寒

作者: 卧龙秋寒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-04 11:30:41 評論於
Have you found it? I haven't found it either
(0) 讚! | 卧龙秋寒

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [ACTA DIABETOLOGICA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*